Literature DB >> 3955920

Sodium fluoride in the treatment of osteoporosis.

G R Power, J D Gay.   

Abstract

Twenty-five patients treated with sodium fluoride, calcium, and Vitamin D (183 person-years of observation) and 24 patients treated with calcium and Vitamin D alone (107 person-years of observation) were compared. The incidence of vertebral fracture was reduced (p less than 0.01) only in the 8 fluoride treated patients who developed radiographic fluorosis. These 8 patients were younger and closer to menopause than those who did not develop fluorosis. Femoral fracture could not be shown to be related to fluoride treatment, but interval from menopause and fall in metacarpal index were found to be useful predictors of this event.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955920

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  5 in total

1.  What is the future for fluoride in the treatment of osteoporosis?

Authors:  J D Ringe; P J Meunier
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

2.  Towards optimization of odonto/osteogenic bioengineering: in vitro comparison of simvastatin, sodium fluoride, melanocyte-stimulating hormone.

Authors:  Vahid Zijah; Roya Salehi; Marziyeh Aghazadeh; Mohammad Samiei; Effat Alizadeh; Soodabeh Davaran
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-03-25       Impact factor: 2.416

Review 3.  Is fluoride treatment justified today?

Authors:  J A Inkovaara
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

Review 4.  Fluoride therapy of type I osteoporosis.

Authors:  J P Devogelaer; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 5.  Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis.

Authors:  T M Murray; L G Ste-Marie
Journal:  CMAJ       Date:  1996-10-01       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.